A role for IFN-αβ in virus infection-induced sensitization to endotoxin

Journal of Immunology

Volumn 166, Issue 4, 2001, Pages 2658-2664

  Doughty, L A ^a   Nguyen, K B ^a   Durbin, J E ^a   Biron, C A ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; ENDOTOXIN; GAMMA INTERFERON; INTERLEUKIN 12; STAT1 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INTERFERON PRODUCTION; LETHALITY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIZATION; SEPTIC SHOCK; VIRUS INFECTION;

EID: 0035865343     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.4.2658     Document Type: Article

References (47)

1. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome
2. Lethal synergism between influenza infection and staphylococcal enterotoxin B in mice
3. Mechanism of interleukin 12-mediated toxicities during experimental viral infections: Role of tumor necrosis factor and glucocorticoids
4. Synergism for cytokine-mediated disease during concurrent endotoxin and viral challenges: Roles for NK and T cell IFN-γ production
5. Influenza, respiratory syncytial, adenovirus, and other respiratory viruses
6. Toxic shock syndrome: A newly recognized complication of influenza and influenza-like illness
7. Synergistic effect in viral-bacterial infection. I. Combined infection of the respiratory tract in mice with parainfluenza virus and Haemophilus influenzae
8. Bacterial superinfetion in chickenpox... but it can occur at any age
9. A case-control study of necrotizing fasciitis during primary varicella
10. Lethal synergism induced in mice by influenza type A and type Ia group B streptococci
11. Superantigen shock in mice with inapparent viral infection
12. Sensitization to lipopolysaccharide in mice with asymptomatic viral infection: The role of T cell dependent production of interferon γ
13. Treatment with bacterial LPS renders genetically resistant C57BL/6 mice susceptible to Theiler's virus-induced demyelinating disease
14. Modification of susceptibility to K. pneumoniae during murine cytomegalovirus infection
15. Orthomyxoviruses
16. Interleukin 12, interferon-γ, and tumor necrosis factor-α are the key cytokines of the generalized Schwartzman reaction
17. Interleukin 12 is produced in vivo during endotoxemia and stimulates synthesis of γ interferon
18. Interleukin-12 is required for interferon-γ production and lethality in lipopolysaccharide-induced shock in mice
19. Interferon-γ, a mediator of lethal lipopolysaccharide-induced Shwartzman-like shock reactions in mice
20. The role of IFN-γ in the pathology of experimental endotoxemia
21. Cachectin/tumor necrosis factor: Production, distribution, and metabolic fate in vivo
22. Passive immunization against cachetin-tumor necrosis factor protects mice from lethal effect of endotoxin
23. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection
24. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice
25. The toxic effects of tumor necrosis factor in vivo and their prevention by cyclo-oxygenase inhibitors
26. Tumor necrosis factor and the acute metabolic response to tissue injury in man
27. Characterization of receptors for human tumor necrosis factor and their regulation by γ-interferon
28. Interferon-γ enhances expression of cellular receptors for tumor necrosis factor
29. Evidence for IFN-γ as a mediator of the lethality of endotoxin and tumor necrosis factor-α
30. IFN-γ and IFN-β independently stimulate the expression of lipopolysaccharide-inducible genes in murine peritoneal macrophages
31. Recombinant IFN-γ synergizes with lipopolysaccharide induce macrophage membrane procoagulants
32. Interferons and other cytokines
33. Role of early cytokines, including alpha and beta interferons (IFN-α/β), in innate and adaptive immune responses to viral infections
34. Interferon-α/β inhibition of interleukin 12 and interferon-γ production in vitro and endogenously during viral infection
35. Interferon-α/β-mediated inhibition and promotion of interferon-γ STAT1 resolves a paradox
36. Biological properties of recombinant α-interferons: 40th anniversary of the discovery of interferons
37. High- and low-dose interferon α-2b in high-risk melanoma: Analysis of intergroup trial E1690/S911l/C9190
38. Aerosolized interferon-α treatment in patients with multi-resistant pulmonary tuberculosis
39. A multicenter study of recombinant interferon-α 2b in the treatment of multibacillary leprosy
40. A block in both early T lymphocyte and natural killer cell development in transgenic mice with high copy numbers of the human CD3∈ gene
41. RAG-1 deficient mice have no mature B and T lymphocytes
42. + T cell in IFN-γ and IL-4 responses to viral infections: Requirements for IL-2
43. Requirement for natural killer cell-produced interferon γ in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration
44. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells
45. Regulation of IFN consensus sequence binding protein expression in murine macrophages
46. γ interferon augments macrophage activation by lipopolysaccharide by two distinct mechanisms, at the signal transduction level via an autocrine mechanism involving tumor necrosis factor α and interleukin 1
47. Interferon-α prevents endotoxin-induced mortality in mice